Effects of Telmisartan on a Murine Model of Non-Alcoholic Steatohepatitis (NASH) and NASH-Related Hepatocellular Carcinoma

被引：0
|
作者：
Shibazaki, Yuichiro
Fujii, Masato
Wakamatsu, Kyoko
Hashiguchi, Taishi
Honma, Taihei
Furuuchi, Miho
Sakurai, Maki
Nishimura, Nobuyo
Yoneyama, Hiroyuki
机构：
来源：
GASTROENTEROLOGY | 2012年 / 142卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S543 / S543
页数：1
相关论文
共 50 条
  • [31] Oral administration of lactic acid bacteria prevents inflammation and steatosis in a murine model of non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma (HCC)
    Tsuji, N.
    Suabjakyong, P.
    Watanabe, Y.
    Kamiya, T.
    Kimoto-Nira, H.
    Kanto, T.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 : 348 - 348
  • [32] Effect of phlebotomy on non-alcoholic steatohepatitis (NASH).
    Nitecki, J
    Jackson, FW
    Allen, ML
    Farr, VL
    Jackson, FW
    GASTROENTEROLOGY, 2000, 118 (04) : A1474 - A1474
  • [33] Progression of disease in non-alcoholic steatohepatitis (NASH)
    Kaplan, KJ
    Katz, DE
    Holtzmuller, KC
    Sjogren, MH
    Goodman, ZD
    LABORATORY INVESTIGATION, 1999, 79 (01) : 164A - 164A
  • [34] Laboratory predictors of non-alcoholic steatohepatitis (NASH)
    Bilici, A
    Unsal, B
    McGee, A
    Bolukoglu, H
    Ankoma-Sey, V
    Edwards, M
    HEPATOLOGY, 1999, 30 (04) : 438A - 438A
  • [35] Clinicopathological characterization of non-alcoholic Steatohepatitis (NASH)-derived hepatocellular carcinoma (HCC) as a patient stratification model in mice
    Takakura, Kazuki
    Fujii, Masato
    Hashiguchi, Taishi
    Shibazaki, Yuichiro
    Yoneyama, Hiroyuki
    Koido, Shigeo
    Homma, Sadamu
    Ohkusa, Toshifumi
    Tajiri, Hisao
    CANCER RESEARCH, 2014, 74 (19)
  • [36] Cowden syndrome complicated with hepatocellular carcinoma possibly originating from non-alcoholic steatohepatitis (NASH)
    Sugihara, Takaaki
    Mandai, Mari
    Koda, Masahiko
    Matono, Tomomitsu
    Nagahara, Takakazu
    Ueki, Masaru
    Murawaki, Yoshikazu
    HEPATOLOGY RESEARCH, 2011, 41 (02) : 189 - 193
  • [37] Liver Transplantation for NASH-related Hepatocellular Carcinoma Offers Comparable Outcomes versus Non-NASH Etiologies of Hepatocellular Carcinoma
    Sadler, E.
    Mehta, N.
    Bhat, M.
    Grant, D.
    Yao, F.
    Sapisochin, G.
    TRANSPLANTATION, 2017, 101 (05) : 35 - 35
  • [38] TRAIL deficiency protects against fibrosis in murine non-alcoholic steatohepatitis (NASH)
    Hirsova, Petra
    Weng, Peggy
    Ibrahim, Samar H.
    Bronk, Steven
    Gores, Gregory J.
    HEPATOLOGY, 2016, 64 : 753A - 754A
  • [39] Inflammatory processes involved in NASH-related hepatocellular carcinoma
    Cannito, Stefania
    Dianzani, Umberto
    Parola, Maurizio
    Albano, Emanuele
    Sutti, Salvatore
    BIOSCIENCE REPORTS, 2023, 43 (01)
  • [40] Increased endoplasmic reticulum (ER) stress in a murine dietary model of steatohepatitis and patients with non-alcoholic steatohepatitis (NASH)
    Rinella, Mary
    Moseley, Richard M.
    Burgess, Zachary
    Elias, Marc
    Smolak, Robin
    Green, Richard M.
    HEPATOLOGY, 2006, 44 (04) : 243A - 243A
12345